University of California San Francisco
Give to UCSF
Valerie Weaver's team discovers why stiff tissue is a risk factor for breast cancer: it spurs immune cells to release DNA-damaging chemicals, which cause the mutations that ultimately lead to cancer.
Andrew Ko, who led UCSF's trials of daraxonrasib based on discovery science, tells what to know about the medicine, the science behind it and what it means for patients. . On the heels of the drug's FDA approval, he
UCSF researchers helped test the first personalized mRNA cancer vaccine shown to prevent melanoma from returning or spreading, marking a breakthrough in cancer treatment.
An international research network led in North America by UC San Francisco (UCSF) has received a $9 million award from the Leducq Foundation, a cardiovascular research funding organization, to uncover
Scientists made universal stem-cell-derived dendritic "immune teacher" cells that can be coated with a patient’s tumor proteins, creating a cancer vaccine that activated tumor-killing T cells in laboratory studies, patient samples, and mouse models.
The number of low and intermediate-risk prostate cancer patients undergoing active surveillance in place of aggressive treatment has tripled to quadrupled over the last 20 years.
MRIs are among the most accurate imaging tests used to diagnose brain tumors, and MRI-based monitoring of tumors guides critical treatment decisions. The clinical standard for measuring tumors
UCSF reserachers discover why people with controlled HIV are at much higher risk for diabetes than HIV-negative people.
Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from an innovative clinical trial called I-SPY
UCSF Health’s Adam Blaisdell, MD, PhD, has been selected as an IGNITE fellow by the Cancer Research Institute (CRI), a New York-based nonprofit that funds and promotes cancer immunotherapy research.
Breast cancer is known to disproportionately affect Asian American women who never smoked. Now, a new study documents a new breast cancer trend.
UCSF experts explain menopause symptoms, hormone replacement therapy (HRT), benefits, risks, and new guidelines to help women make informed treatment decisions.
UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They are also addressing the limitations holding the field back: giving organoids a vascular system and making organoids reproducible.
UCSF’s Dr. Pamela Ling explains why the FDA’s Zyn ruling risks a new generation of nicotine addiction, despite being marketed as a safer cigarette alternative.
Roarke Kamber earns funding for research that directs the immune system’s “big eaters,” macrophages, to eat tumor cells.
See three examples of how food and lifestyle choices — from plant-based eating to ketogenic diets — help slow cancer progression, improve survival, and make some existing cancer treatments more effective.
A new UCSF study looks at the real reasons women with HIV are dying earlier than people without HIV, and finds these leading causes are largely missing from official death records.
A UCSF team developed an automated system for seeing and understanding persister cells, the tumor cells that survive cancer treatment and regrow tumors.
A new study of more than 16,000 people who sought help from a nationwide abortion and miscarriage hotline found demand for confidential clinical support surged both before and after the U.S. Supreme Court decision that overturned federal abortion protections.
A study looked at how ultraprocessed foods (UPFs), like Lunchables, are designed—and why they may lead to overeating and weight gain. Using internal company documents, the study showed that Lunchables were influenced by strategies from the tobacco industry, specifically Philip Morris, which once owned Kraft.
Using AI on mammograms can identify patients at highest risk for breast cancer and get them same-day follow up care, eliminating stressful waiting times.
Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National Academy of Sciences — one of the highest honors in American science.
Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.
A team of researchers discover how the <i>stentor</i>, an organism made of a single, gigantic cell, learns without a brain.
Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of UCSF’s Pancreas Center, shared her insights on pancreatic cancer on April 16 when she presented the 2026 Byers Award Lecture in Basic Science.
UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a functional cure.
A special program developed by the University of California Health system and adopted at all six UC academic medical centers has been effective in reducing hypertension in patients and could be used by other health systems looking to standardize chronic disease care.
